Contribution of the endothelin system to the renal hypoperfusion associated with experimental congestive heart failure

Journal of Cardiovascular Pharmacology

Volumn 34, Issue 4, 1999, Pages 612-617

  Friedrich, Erik B ^a   Muders, Frank ^a   Luchner, Andreas ^a   Dietl, Otto ^a   Riegger, Günter A J ^a   Elsner, Dietmar ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

BQ 123; Endothelin 1; ET(A) receptor; Heart failure; Rabbit; Renal hemodynamics

Indexed keywords

ADRENALIN; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; MESSENGER RNA; PROTEIN PRECURSOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE ASSOCIATION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEART RATE VARIABILITY; KIDNEY BLOOD FLOW; KIDNEY CIRCULATION; KIDNEY DISEASE; KIDNEY PERFUSION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RABBIT; TISSUE LEVEL; VASOCONSTRICTION;

ANIMALS; BLOTTING, NORTHERN; ECHOCARDIOGRAPHY; ENDOTHELIN-1; EPINEPHRINE; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; LASER-DOPPLER FLOWMETRY; MALE; PEPTIDES, CYCLIC; RABBITS; RADIOIMMUNOASSAY; RECEPTORS, ENDOTHELIN; RENAL ARTERY; RNA; SYMPATHOMIMETICS;

EID: 0032831006     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199910000-00020     Document Type: Article

References (30)

1. Packer M. Neurohumoral interactions and adaptations in congestive heart failure. Circulation 1988;77:721-30.
2. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-5.
3. Lerman A, Hildebrand FLJ, Margulies KB, et al. Endothelin: a new cardiovascular regulatory peptide. Mayo Clin Proc 1990;65:1441-55.
4. Rodeheffer RJ, Lerman A, Heublein DM, Burnett JC. Concentrations of endothelin in congestive heart failure in humans. Mayo Clin Proc 1992;67:719-24.
5. Wei CM, Lerman A, Rodeheffer RJ, et al. Endothelin in human congestive heart failure. Circulation 1994;89:1580-6.
6. Hocher B, Thone-Reinecke C, Bauer C, Raschack M, Neumayer HH. The paracrine endothelin system: pathophysiology and implications in clinical medicine. Eur J Clin Chem Clin Biochem 1997; 35:175-89.
7. Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 1990;348:730-2.
8. Lerman A, Hildebrand FLJ, Aarhus LL, Burnett JC. Endothelin has biological actions at physiological concentrations. Circulation 1991;83:1808-14.
9. Hosoda K, Nakao K, Tamura N, et al. Organization, chromosomal assignment, and expression of the gene encoding the human endothelin-A receptor. J Biol Chem 1992;267:18797-804.
10. Huggins J, Pelton J, Miller R. The structure and specificity of endothelin receptors: their importance in physiology and medicine. Pharmacol Ther 1993;59:55-123.
11. Clavell AL, Bumett JC. Physiologic and pathophysiologic roles of endothelin in the kidney. Curr Opin Nephrol Hypertens 1994;3: 66-72.
12. King AJ, Brenner B, Anderson S. Endothelin: a potent renal and systemic vasoconstrictor peptide. Am J Physiol 1989;256: F1051-8.
13. Rubinstein I, Gurbanov K, Hoffman A, Better OS, Winaver J. Differential effect of endothelin-1 on renal regional blood flow: role of nitric oxide. J Cardiovasc Pharmacol 1995;26(suppl 3): S208-10.
14. Muders F, Luchner A, Friedrich E, Riegger GAJ, Eisner D. Modulation of renal blood flow by endogenous endothelin-1 in conscious rabbits with low cardiac output state. Am J Hypertens 1998;11: 37A.
15. A receptor. Life Sci 1992a;50:247.
16. Krämer BK, Riegger GAJ. Circulatory and myocardial effects of endothelin. J Mol Med 1997;75:886-90.
17. Muders F, Kromer EP, Griese DP, et al. Evaluation of plasma natriuretic peptides as markers for left ventricular dysfunction. Am Heart J 1997;134:442-9.
18. Luchner A, Stevens TL, Borgeson DD, et al. Angiotensin II in the evolution of experimental heart failure. Hypertension 1996;28: 472-7.
19. Lowry OH, Rosebrough NJ, Farr L, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;192:265-75.
20. Chirgwin JN, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979;18:5249-99.
21. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor: CSH Laboratory Press, 1989.
22. Khandjian EW. UV crosslinking of RNA to nylon membranes enhances hybridization signals. Mol Biol Rep 1986;11:107-15.
23. Inoue A, Yanagisawa M, Kimura S, et al. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA 1989;86:2863-7.
24. Pupilli C, Brunori M, Misciglia N, et al. Presence and distribution of endothelin-1 gene expression in human kidney. Am J Physiol 1994;267:F679-87.
25. Ritthaler T, Gopfert T, Firth J, Ratcliffe P, Krämer B, Kurtz A. Influence of hypoxia on hepatic and renal endothelin gene expression. Pflugers Arch 1996;431:587-93.
26. Pieske B, Beyermann B, Breu V, et al. Functional effects of endothelin and regulation of endothelin receptors in isolated human nonfailing and failing myocardium. Circulation 1999;99:1802-9.
27. A receptor blockade in chronic heart failure patients treated with ACE inhibitors. Circulation 1996;94:2131-7.
28. Sakai S, Miyauchi T, Kobayashi M, Yamaguchi I, Goto K, Sugishita Y. Inhibition of myocardial endothelin pathway improves long-term survival in heart failure. Nature 1996;384:353-5.
29. Spinale FG, Walker JD, Mukherjee R, Iannini JP, Keever AT, Gallagher KP. Concomitant endothelin receptor subtype-a blockade during the progression of pacing-induced congestive heart failure in rabbits. Circulation 1997;95:1918-29.
30. Borgeson DD, Grantham JA, Williamson EE, et al. Chronic oral endothelin type A receptor antagonism in experimental heart failure. Hypertension 1998;31:766-70.